[1]
Dembele, O. et al. 2022. Risk-Based Post-Marketing Surveillance (RB-PMS) of antimalarial drugs and maternal, neonatal and reproductive health (MNCH) in Mali. Journal of Drug Delivery and Therapeutics. 12, 2 (Mar. 2022), 6–10. DOI:https://doi.org/10.22270/jddt.v12i2.5223.